SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 319 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is 0.43 and the average weighting 1.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $31,551,000 | -9.8% | 182,800 | -39.9% | 0.06% | -10.1% |
Q4 2014 | $34,965,000 | -99.9% | 304,200 | +0.3% | 0.07% | +9.5% |
Q3 2014 | $47,381,343,000 | +16.2% | 303,260 | -8.3% | 0.06% | +23.5% |
Q2 2014 | $40,786,911,000 | +4.7% | 330,660 | -12.1% | 0.05% | +15.9% |
Q1 2014 | $38,967,721,000 | -38.7% | 376,100 | -46.8% | 0.04% | -44.3% |
Q4 2013 | $63,524,622,000 | +24.9% | 706,300 | -7.1% | 0.08% | -35.8% |
Q3 2013 | $50,842,176,000 | -3.7% | 760,200 | -4.8% | 0.12% | -12.1% |
Q2 2013 | $52,800,930,000 | – | 798,200 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |